Dr. Daniel P. Lupash, M.D.
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- Loyola University of Chicago, Stritch School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 184
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: Loyola University of Chicago, Stritch School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
UT license 6360119-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Intermountain Health Mckay-Dee Hospital Ogden, UT
- Intermountain Health Layton Hospital Layton, UT
Medical groups
- Ihc Health Services Inc (3,960 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 184
- Services billed
- 32,504
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, infliximab, excludes biosimilar, 10 mg | 7,328 | 20 |
| Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,550 | 11 |
| Injection, denosumab, 1 mg | 2,280 | 21 |
| Established patient office or other outpatient visit, 30-39 minutes | 382 | 176 |
| Insertion of needle into vein for collection of blood sample | 270 | 117 |
| Administration of chemotherapy into vein, each additional hour | 221 | 37 |
| Administration of chemotherapy into vein, 1 hour or less | 194 | 37 |
| Established patient office or other outpatient visit, 40-54 minutes | 171 | 95 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 60 | 13 |
| Injection of drug or substance under skin or into muscle | 45 | 22 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Methotrexate (methotrexate sodium) Other prescribers in Ogden, UT | 266 |
| Hydroxychloroquine Sulfate Other prescribers in Ogden, UT | 206 |
| Prednisone Other prescribers in Ogden, UT | 112 |
| Folic Acid Other prescribers in Ogden, UT | 65 |
| Leflunomide Other prescribers in Ogden, UT | 45 |
| Tramadol Hcl Other prescribers in Ogden, UT | 39 |
| Celecoxib Other prescribers in Ogden, UT | 36 |
| Enbrel Sureclick (etanercept) Other prescribers in Ogden, UT | 35 |
| Meloxicam Other prescribers in Ogden, UT | 34 |
| Enbrel (etanercept) Other prescribers in Ogden, UT | 31 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.